Information for Accepted Poster Presenters:
The posters will be displayed in the Exhibition venue (the Ballroom) at the Cape Town International Convention Centre (CTICC).

The maximum size for posters is 841mm (W) x 1189mm (H); A0 paper size.

Posters should be affixed to the boards between 08h00 and 14h00 on Wednesday, 24 September 2014.

Posters should be affixed to the boards using Prestik or double-sided tape only. No thumb-tacks or nails are permitted to be used.

Posters are to be removed on Saturday, 27 September 2014 after 14h00.

Poster viewing will take place during Conference tea breaks and lunch breaks.


Information for Accepted Oral Presenters: 
The allocated total time per presentation is 10 minutes.

The oral abstract presentation session will be taking place from 13h30 on Thursday, 25 September 2014.

Further information will be sent via email however should you have any queries please contact Janice Candlish on Janice@soafrica.com or +27 (0) 11 463 5085.


NB: The submitting clinician must receive patient consent for any images provided and ensure that identifying features of the case, including names on labs or images, are removed.

Presenting authors agree to register for and attend the conference. Oral abstract and poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.


1. Antiretroviral Treatment
This track includes sessions on new antiretroviral therapies, outcomes of existing antiretroviral therapy regimens, complications of HIV-infection and ART (e.g. renal, hepatic, bone, lipid and glucose disorder), management and prevention of HIV drug resistance, retention in care
2. Children and Adolescents
This track includes sessions on the prevention and management of HIV and related conditions in paediatric and adolescent populations, to include PMTCT, neonatal treatment, outcomes and complications of ART, treatment failure, adolescent-specific challenges and retention in care.
3. Clinical Skills Building
This track includes interactive, case-based sessions and practical skills-based sessions. Clinical cases submitted should comprise of clinical scenarios that highlight valuable lessons and or key teaching points for the clinician at the coal face. Unusual or complex presentations that highlight the intricacies of HIV clinical decision-making are welcome. Cases should encompass HIV and related opportunistic conditions. Accepted cases will be presented to an expert panel for discussion.
4. Monitoring and Diagnostics
This track includes sessions on relevant laboratory and diagnostic issues, including point of care testing, implementation and use of GeneXpert, genotypic testing and monitoring strategies
5. Primary Care
This track will include sessions to enhance the clinical skills of primary care practitioners working in the field of HIV. Emphasis will be on the challenges and strategies to managing HIV and other conditions in an outpatient setting.
6. Non-TB Ols
This track includes HIV-related and non-related malignancies, cryptococcal meningitis, STDs and other OIs
7. Operational / Programmatic
This track includes interventions at the facility or programmatic level that improve HIV prevention, care and treatment
8. Prevention
This track includes biomedical HIV prevention methods, treatment as prevention and structural and behavioural interventions to reduce HIV transmission
9. TB
This track will cover all aspects of TB as it relates to HIV, including integration, co-management, complications and M/XDR TB
10. Women
This track includes sessions specific to women at risk of or living with HIV with topics covering fertility, HIV in pregnancy, the long-term impacts of ART in women and cervical cancer

The conference scientific committee will select the top 10data-driven abstracts, which will be featured in a “best abstracts” session during the conference and published in the March 2015 issue of the Southern African Journal of HIV Medicine. The top abstract will be awarded R8000.

The scientific committee will also recognise the top 3 clinical case descriptions. These cases will be presented to an expert panel during the conference, and the top case will be published in the March 2015 issue of the Southern African Journal of HIV Medicine. The top case will also be awarded R6000.

For assistance or more information on abstract submission please contact:
Janice Candlish
Scatterlings Conference & Events
Email: janice@soafrica.com
Tel: +27 (0) 11 463 5085